GGrantIndex
Sort

50,496 grants matching lung cancer

Mechanistic and therapeutic investigation of secondary metastatic seeding from breast cancer bone lesion

$485,943
Xiang Zhang · Baylor College Of Medicine · R01 · FY2021 · CA

RAD51 Inhibitors for Chemotherapy and Radiation Therapy

$485,934
Philip Paul Connell · University Of Chicago · R01 · FY2019 · CA

Contribution of development and age to breast cancer etiology

$485,895
Mary Helen Barcellos-Hoff · University Of California, San Francisco · R01 · FY2019 · CA

The Role of Inflammation in Regulating Gastritis and Gastric Carcinogenesis

$485,826
Richard J Dipaolo · Saint Louis University · R56 · FY2021 · DK

RNA Nanotechnology in Cancer Therapy

$485,825
Peixuan Guo · University Of Cincinnati · U01 · FY2010 · CA

The Effect of Isothiocyanate Consumption on NNAL Metabolism in Smokers

$485,790
Anna Karolina Hull · Lincoln University · P20 · FY2012 · MD

Mechanisms of Variant ER-alpha Function in Breast Cancer

$485,788
Elaine T Alarid · University Of Wisconsin-Madison · R01 · FY2021 · CA

Implementation of Smoking Cessation Services within NCI NCORP Community Sites with Organized Lung Cancer Screening Programs

$485,787
Kristie L Foley · Wake Forest University Health Sciences · R01 · FY2018 · CA

Improving Risk Factors for Diabetes Complications in Primary Care

$485,783
Michael L Parchman · University Of Texas Hlth Science Center · R18 · FY2009 · DK

MARIJUANA USE AND THE RISKS OF LUNG AND OTHER CANCERS

$485,780
University Of California Los Angeles · R01 · FY2000 · DA

Project 2: Functional Genetic Networks for Systems-Guided Precision Medicine

$485,626
Stephanie Irene Fraley · University Of California, San Francisco · U54 · FY2024 · CA

Understanding EGF receptor activation by growth factors and oncogenic mutations

$485,609
Mark A. Lemmon · Yale University · R01 · FY2016 · CA

Targeting the metastasis initiating cell in undifferentiated pleomorphic sarcoma

$485,589
Benjamin Aaron Alman · Duke University · R01 · FY2021 · CA

A novel, glutathione-dependent metabolic pathway drives metastatic outgrowth in pancreatic cancer

$485,558
Raul Mostoslavsky · Massachusetts General Hospital · R01 · FY2025 · CA

A novel, glutathione-dependent metabolic pathway drives metastatic outgrowth in pancreatic cancer

$485,558
Raul Mostoslavsky · Massachusetts General Hospital · R01 · FY2024 · CA

Translating CBT-Insomnia for Lung Cancer into practice: A RCT

$485,532
Grace E Dean · State University Of New York At Buffalo · R15 · FY2013 · NR

Role of the METTL13 Lysine Methyltransferase in Signaling and Cancer

$485,495
Or P. Gozani · Stanford University · R01 · FY2020 · CA

Interrogating the relationship between translational dynamics and non-canonical antigen presentation in lung cancer

$485,494
Alex Jaeger · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA

Interrogating the relationship between translational dynamics and non-canonical antigen presentation in lung cancer

$485,494
Alex Jaeger · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA

Targeting DNA repair in KRAS mutated lung cancer by chemical screening

$485,475
You-Wei Zhang · Case Western Reserve University · R01 · FY2021 · CA

Targeted Sequencing of 3 Loci Associated with BMD in the Framingham Osteoporosis

$485,446
Douglas P. Kiel · Hebrew Rehabilitation Center For Aged · R01 · FY2012 · AR

Community Outreach and Engagement

$485,385
Judith R Rees · Dartmouth College · P30 · FY2025 · CA

Nonlinear performance analysis and prediction for robust low dose lung CT

$485,340
Jianan Grace Gang · University Of Pennsylvania · R01 · FY2024 · CA

Clinical Diagnostic Studies and Treatment of Patients with Immune Deficiencies

$485,200
Harry L Malech · Niaid Extramural Activities · Z01 · FY2007 · AI

Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs

$485,193
Joseph C Wu · Stanford University · R01 · FY2015 · HL